Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2021, Vol. 41 Issue (11): 119-123    DOI: 10.13523/j.cb.2108030
    
Current Situation and Development Suggestions of China’s Biotechnology Base Platform
WU Han-rong,WANG Ying,YANG Li,GE Yao,FAN Ling()
China National Center for Biotechnology Development,Beijing 100081,China
Download: HTML   PDF(411KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Biotechnology is the core of the new round of scientific and technological revolution and industrial change since the 21st century, while the biotechnology base platform is an important scientific and technological innovation body to carry out biotechnology research, production and services, and is an important part of the development of biotechnology. This paper analyzes the overall scale and construction of biotechnology base platform in the world’s major developed countries and China, draws lessons from international experience, and puts forward policy suggestions to improve the construction of biotechnology base platform in China for reference.



Key wordsBiotechnology      Base      platform      Policies      Development      status     
Received: 11 August 2021      Published: 01 December 2021
ZTFLH:  Q819  
Corresponding Authors: Ling FAN     E-mail: fanling@cncbd.org.cn
Cite this article:

WU Han-rong,WANG Ying,YANG Li,GE Yao,FAN Ling. Current Situation and Development Suggestions of China’s Biotechnology Base Platform. China Biotechnology, 2021, 41(11): 119-123.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.2108030     OR     https://manu60.magtech.com.cn/biotech/Y2021/V41/I11/119

基地平台类型 美国 加拿大 英国 德国 法国 瑞士 日本 总计 占比/%
科学与工程研究类 国家(重点)实验室、国立/州立科研机构等 254 74 50 60 7 21 55 521 29.8
技术创新与成果转化类 国家(临床)医学研究中心、企业研究中心、
产业园区等
314 137 146 127 117 41 145 1 027 58.7
基础支撑与条件保障类 资源共享平台等 142 - 9 4 - 2 45 202 11.5
总计 710 211 205 191 124 64 245 1 750 100
Table 1 Distribution of biotechnology base platforms in key countries in the world
序号 基地平台类型 二级类目 数量
1 科学与工程研究类基地平台 国家重点实验室 74
2 省部共建国家重点实验室 31
3 企业国家重点实验室 31
4 技术创新与成果转化类基地平台 国家国际科技合作基地 163
5 国家工程技术研究中心 98
6 国家工程研究中心 29
7 国家临床医学研究中心 50
8 国家中药现代化科技产业基地 25
9 国家高新技术产业开发区 165
10 国家技术创新中心 1
11 基础支撑与条件保障类基地平台 国家生物种质资源库 179
12 国家人类遗传资源库 105
13 国家大型科学仪器中心 11
14 国家重大科技基础设施 13
15 国家科学数据中心 11
Table 2 Summary of China’s National Biotechnology Base Platforms
[1]   科技部. “十三五”国家科技创新基地与条件保障能力建设专项规划.[2017-10-24]. http://www.most.gov.cn/xxgk/xinxifenlei/fdzdgknr/fgzc/gfxwj/gfxwj2017/201710/t20171026_135754.html .
[1]   Ministry of Science and Technology. The 13th Five-Year Plan for the construction of national science and technology innovation base and condition guarantee capacity.[2017-10-24]. http://www.most.gov.cn/xxgk/xinxifenlei/fdzdgknr/fgzc/gfxwj/gfxwj2017/201710/t20171026_135754.html .
[2]   中国生物技术发展中心. 2019中国生物技术基地平台报告. 北京: 科学技术文献出版社, 2019: 4.
[2]   China National Center for Biotechnology Development. 2019 China biotechnology base and platform report. Beijing: Scientific and Technical Documents Publishing House, 2019: 4.
[3]   王飞. 美国生物医药产业创新的升级规律及启示. 南京社会科学, 2019(8):29-35.
[3]   Wang F. Upgrading law and enlightenment of biopharmaceutical innovation in USA. Nanjing Journal of Social Sciences, 2019(8):29-35.
[4]   王永宁. 日本生物技术研究开发推进管理.全球科技经济瞭望, 2003(3):8-9.
[4]   Wang Y N. Promotion management of Japanese biotechnology research and development. Global Science,Technology and Economy Outlook, 2003(3):8-9.
[5]   吴函蓉, 夏凡, 杨力, 等. 德国生物技术发展的经验及启示. 科技中国, 2018(12):27-29.
[5]   Wu H R, Xia F, Yang L, et al. Experience and enlightenment of biotechnology development in Germany, China Scitechnology Business, 2018(12):27-29.
[6]   付红波, 李玉洁, 苏月, 等. 加拿大生物科技及产业发展现状及特点. 中国生物工程杂志, 2010, 30(5):149-152.
[6]   Fu H B, Li Y J, Su Y, et al. Development status and characteristics of biotechnology and industry in Canada, China Biotechnology, 2010, 30(5):149-152.
[7]   王涛, 杨正. 美国生物技术领域政策研究. 全球科技经济瞭望, 2020, 35(3):1-6.
[7]   Wang T, Yang Z. Research on the policies of biotechnology in the US. Global Science, Technology and Economy Outlook, 2020, 35(3):1-6.
[8]   李碧花, 董瀛飞. 创新型区域的形成路径与运行机制:以生物技术产业的国际比较为例. 山东社会科学, 2011(7):150-153.
[8]   Li B H, Dong Y F. Formation path and operation mechanism of innovative region: a case study of international comparison of biotechnology industry.Shandong Social Sciences, 2011(7):150-153.
[9]   国家统计局. 2020年全国规模以上工业企业利润增长4.1%.[2021-01-27]. http://www.stats.gov.cn/tjsj/zxfb/202101/t20210127_1812824.html .
[9]   National Bureau of Statistics. Profits of nationwide industrial enterprises above state designated scale rose 4.1% in 2020.[2021-01-27]. http://www.stats.gov.cn/tjsj/zxfb/202101/t20210127_1812824.html .
[10]   中国生物技术发展中心. 2020中国生物技术基地平台报告. 北京: 科学技术文献出版社, 2020: 4.
[10]   China National Center for Biotechnology Development. 2020 China biotechnology base and platform report. Beijing: Scientific and Technical Documents Publishing House, 2020: 4.
[1] LIU Xu-xia,YANG An-ke. An Analysis of the U.S. SECURE Rule and Its Enlightenment to China[J]. China Biotechnology, 2021, 41(9): 126-135.
[2] WU Xiu-zhi,WANG Hong-jie,ZU Yao. Functional Study of hoxa1a Regulating Craniofacial Bone Development in Zebrafish[J]. China Biotechnology, 2021, 41(9): 20-26.
[3] ZHAO Xia,ZHU Zhe,ZU Yao. tbx2b Affects Atrioventricular Canal Development in Zebrafish[J]. China Biotechnology, 2021, 41(8): 1-7.
[4] GE Qi,ZHANG Peng,HAN Ming-zhe,YANG Jin-sheng,ZHANG Da-lu,CHEN Wei-gang. Signal Processing for Nanopore Sequencing and Its Application in DNA Data Storage[J]. China Biotechnology, 2021, 41(8): 75-89.
[5] HU Yuan-lei,CHEN Yan-cheng,PU Run,YAO Wei-hao,ZHANG Hong-xiang. Bio-tech Startup Incubation Best Practice in the United Kingdom and Suggestion[J]. China Biotechnology, 2021, 41(4): 100-105.
[6] ZHOU Zi-hui,LIU Xiao-xian,HUANG Hao,XIAO Rui,QI Ke-zong,WANG Sheng-qi. Application of Surface-enhanced Raman Scattering Based onNano-signal Tags in Pathogen Detection[J]. China Biotechnology, 2021, 41(2/3): 70-77.
[7] HE Wei,ZHU Lei,LIU Xin-ze,AN Xue-li,WAN Xiang-yuan. Research Progress on Maize Genetic Transformation and Commercial Development of Transgenic Maize[J]. China Biotechnology, 2021, 41(12): 13-23.
[8] WU Han-rong,WANG Ying,HUANG Ying-ming,LI Dong-xue,LI Zhi-fei,FANG Zi-han,FAN Lin. Promote the Innovation and Transformation of Biotechnology by Base Platform[J]. China Biotechnology, 2021, 41(12): 141-147.
[9] MAO Kai-yun,LI Rong,LI Dan-dan,ZHAO Ruo-chun,FAN Yue-lei,JIANG Hong-bo. Analysis of the Current Status of Global Bispecific Antibody Development[J]. China Biotechnology, 2021, 41(11): 110-118.
[10] WU Han-rong,WANG Ying,LI Su-ning,SANG Xiao-dong,FAN Ling. Policy Research on the Construction of Biotechnology Base Platforms in China[J]. China Biotechnology, 2021, 41(10): 127-131.
[11] MENG Xiao-lin,PANG Xi-ming,WANG Jie. Agrobacterium-mediated Transformation and the Functions of Pks in Marine-derived Penicillium oxalicum[J]. China Biotechnology, 2020, 40(9): 11-17.
[12] SONG Yi-mei,JIA Xiu-wei,LI Shu-biao,GAO Cui-juan. Industrial Microorganism of Yarrowia lipolytica and Its Industrial Amplicaiton[J]. China Biotechnology, 2020, 40(9): 77-86.
[13] WANG Xiao-li. The Age of Biosecurity: New Biotechnology Revolution and National Biosecurity Governance[J]. China Biotechnology, 2020, 40(9): 95-109.
[14] BAI Jing-yu,LIN Xiao-feng,YIN Zheng-qing. Analysis of the Current Situation and Development Trend of Global Biotechnology Research Based on Bibliometrics[J]. China Biotechnology, 2020, 40(7): 100-109.
[15] ZHOU Qin,WANG Shuang,ZHANG Ting,LI Shan-gang,CHEN Yong-chang. T158M Single Base Editing of MECP2 Gene in Murine and Rhesus Monekey’s Embryos[J]. China Biotechnology, 2020, 40(6): 31-39.